U.S. President Donald Trump speaks in the Oval Office after signing an Executive Order on April 18, 2026, in Washington, D.C. The executive order directs the Food and Drug Administration to issue new guidance on the use of psychedelic drugs intended for clinical trials for U.S. veterans suffering from Post Traumatic Stress Disorder.
English (US)